Rubedo’s RLS-1496 Trial: Anti-Aging Breakthrough Meets Crypto’s Disruptive Spirit
Rubedo’s RLS-1496: Anti-Aging Meets the Crypto Spirit in a Groundbreaking Trial Rubedo Life Sciences has dropped a bombshell in the biotech world with the first human trial results for RLS-1496, a drug targeting the “zombie” cells behind skin aging. Beyond the science, this breakthrough resonates with the crypto crowd—think disruption, decentralization, and a big middle […]
Read Full Article